Indoco Remedies reports Q4FY19 revenue at Rs 245 crores
The EBIDTA reported by the company stood at Rs 28.5 crores, while the Profit after Tax (PAT) stood at Rs 11.6 crore for Q4FY19
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Biocon Academy introduces Experiential Learning Program in ‘Quality Control Analytical’
Under the program, subject matter experts from Biocon and M S Ramaiah College’s faculty will impart real world insights and hands…
Glenmark’s consolidated revenue rises 12.44 per cent to Rs 25,634.74 million for Q4 FY 2018-19
Consolidated net profit rises 6.62 per cent to Rs 1,616.62 million for Q4 FY 2018-19
Lupin wins Packaging Award for ‘Lupin Sahayak’
'Lupin Sahayak' is a new patient's awareness initiative byLupin’s Synox Team, that focuses on diabetes and hypertension
Fermenta Biotech’s Dahej facility’s de-bottlenecking complete
The plant had undergone a routine shutdown for repairs and maintenance along with a de-bottlenecking programme for capacity…
Lupin wins India Packaging Award for ‘Corcal Bone & Beauty’
Corcal is the latest launch by the company’s Consumer Healthcare Business, LupinLife
Addressable market for e-pharmacies in India to reach $18.1 bn by 2023
As per the report 'E-pharma: Delivering Healthier Outcomes' by consultancy firm EY, the addressable medicine market for…
Cadila Healthcare posts Q4 net profit of Rs 460 cr
The company said its board has recommended a dividend of Rs 3.50 per equity share on 1,02,37,42,600 equity shares of Re 1 each for…
Pharma industry gearing up to rapidly changing regulatory norms
By 2020, many branded medicines are going off-patent and there will be an ocean of opportunities for big- and medium-sized pharma…
Vizag Pharma Summit deliberates on the future of Brand India Pharma
The theme of the maiden Vizag Pharna Summit was Shaping the future of Brand India Pharma
Usha Sharma -- Vizag
After the…